Easing US restrictions on mitochondrial replacement therapy would protect research interests but grease the slippery slope
Crossref DOI link: https://doi.org/10.1007/s10815-019-01529-3
Published Online: 2019-08-28
Published Print: 2019-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Keefe, David L. http://orcid.org/0000-0001-6704-6343
Text and Data Mining valid from 2019-08-28
Version of Record valid from 2019-08-28
Article History
Received: 3 July 2019
Accepted: 8 July 2019
First Online: 28 August 2019